What Happened?
New York, NY-based Redpin-Therapeutics Appointed Elma Hawkins as President and Chief Executive Officer, Co-Founder
About the Company
Welcome to Redpin Therapeutics. We are a privately held, preclinical stage gene therapy company based in New York City. We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy.
About the Person
Elma Hawkins is President and Chief Executive Officer, Co-Founder at Redpin Therapeutics. Previously, Elma held various senior HR leadership roles in the industry.
Info Source
News
Short Profile